NO20065270L - Polymerkonjugat som kan frigjores ved milde tiolyttiske betingelser - Google Patents
Polymerkonjugat som kan frigjores ved milde tiolyttiske betingelserInfo
- Publication number
- NO20065270L NO20065270L NO20065270A NO20065270A NO20065270L NO 20065270 L NO20065270 L NO 20065270L NO 20065270 A NO20065270 A NO 20065270A NO 20065270 A NO20065270 A NO 20065270A NO 20065270 L NO20065270 L NO 20065270L
- Authority
- NO
- Norway
- Prior art keywords
- conditions
- under mild
- thiolite
- polymer conjugate
- released under
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title 1
- 150000001412 amines Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000006227 byproduct Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- -1 polyethylene glycol Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
- C07C329/02—Monothiocarbonic acids; Derivatives thereof
- C07C329/04—Esters of monothiocarbonic acids
- C07C329/10—Esters of monothiocarbonic acids having sulfur atoms of thiocarbonic groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0039—Coumarin dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
- C07C329/02—Monothiocarbonic acids; Derivatives thereof
- C07C329/04—Esters of monothiocarbonic acids
- C07C329/08—Esters of monothiocarbonic acids having sulfur atoms of thiocarbonic groups bound to carbon atoms of rings other than six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56456504P | 2004-04-21 | 2004-04-21 | |
| PCT/US2005/013367 WO2005105154A1 (en) | 2004-04-21 | 2005-04-20 | Polymer conjugate releasable under mild thiolytic conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065270L true NO20065270L (no) | 2007-01-17 |
Family
ID=37450607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065270A NO20065270L (no) | 2004-04-21 | 2006-11-16 | Polymerkonjugat som kan frigjores ved milde tiolyttiske betingelser |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050265925A1 (ko) |
| EP (1) | EP1748795A1 (ko) |
| KR (1) | KR20070010175A (ko) |
| CN (1) | CN1997399A (ko) |
| AU (1) | AU2005238015A1 (ko) |
| CA (1) | CA2562527A1 (ko) |
| IL (1) | IL178561A0 (ko) |
| MX (1) | MXPA06012144A (ko) |
| NO (1) | NO20065270L (ko) |
| WO (1) | WO2005105154A1 (ko) |
| ZA (1) | ZA200609638B (ko) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100255050A1 (en) * | 2007-07-24 | 2010-10-07 | James Klein Leonard | Polyethylene Based Bioactive Agents |
| US9901567B2 (en) | 2007-08-01 | 2018-02-27 | Syntarga B.V. | Substituted CC-1065 analogs and their conjugates |
| BRPI0921687A8 (pt) | 2008-11-03 | 2022-11-08 | Syntarga Bv | Composto , conjugado , uso de um composto , composição farmacêutica, processo para preparar uma composição famacêutica , método para tratar um mamífero em necessidade do mesmo ,e, método para tratar ou prevenir um tumor em um mamífero. |
| PL3056203T3 (pl) | 2010-04-21 | 2018-06-29 | Syntarga B.V. | Koniugaty analogów CC-1065 i łączników dwufunkcyjnych |
| ES2755719T3 (es) | 2012-04-05 | 2020-04-23 | Nerviano Medical Sciences Srl | Nuevos agentes alquilantes |
| JP6251236B2 (ja) | 2012-04-05 | 2017-12-20 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | 癌を治療するための官能性チエノ−インドール誘導体 |
| CN104755482B (zh) | 2012-10-30 | 2017-04-26 | 内尔维阿诺医学科学有限公司 | 官能化的9‑溴‑喜树碱衍生物 |
| US10266547B2 (en) | 2013-09-25 | 2019-04-23 | Nerviano Medical Sciences S.R.L. | Thieno[2,3-e]indole derivatives as new antitumor agents |
| PT3092010T (pt) | 2014-01-10 | 2018-09-28 | Synthon Biopharmaceuticals Bv | Método para purificação de conjugados anticorpo-fármaco ligados por cys |
| RU2715902C2 (ru) | 2014-11-05 | 2020-03-04 | НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. | Функционализированные производные морфолинилантрациклина |
| EP3604386B1 (en) | 2017-03-30 | 2022-04-06 | NOF Corporation | Degradable polyethylene glycol derivative having disulfide linker |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| GB8430252D0 (en) * | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
| US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US4917888A (en) * | 1985-06-26 | 1990-04-17 | Cetus Corporation | Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation |
| US5103556A (en) * | 1988-05-05 | 1992-04-14 | Circon Corporation | Method of manufacturing an electrohydraulic probe |
| US4902502A (en) * | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
| ES2247656T3 (es) * | 1989-04-19 | 2006-03-01 | Enzon, Inc. | Un proceso para formar un polipeptido modificado que comprende un polipeptido y un oxido de polialquileno. |
| US5395619A (en) * | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| WO1998016201A1 (en) * | 1996-10-11 | 1998-04-23 | Sequus Pharmaceuticals, Inc. | Therapeutic liposome composition and method |
| US6214330B1 (en) * | 1998-07-13 | 2001-04-10 | Enzon, Inc. | Coumarin and related aromatic-based polymeric prodrugs |
| EP1880736A1 (en) * | 1999-04-23 | 2008-01-23 | Alza Corporation | Releasable linkage and composition containing same |
-
2005
- 2005-04-20 AU AU2005238015A patent/AU2005238015A1/en not_active Abandoned
- 2005-04-20 US US11/110,272 patent/US20050265925A1/en not_active Abandoned
- 2005-04-20 WO PCT/US2005/013367 patent/WO2005105154A1/en active Application Filing
- 2005-04-20 CA CA002562527A patent/CA2562527A1/en not_active Abandoned
- 2005-04-20 MX MXPA06012144A patent/MXPA06012144A/es not_active Application Discontinuation
- 2005-04-20 KR KR1020067023899A patent/KR20070010175A/ko not_active Application Discontinuation
- 2005-04-20 ZA ZA200609638A patent/ZA200609638B/xx unknown
- 2005-04-20 EP EP05738176A patent/EP1748795A1/en not_active Withdrawn
- 2005-04-20 CN CNA2005800126244A patent/CN1997399A/zh active Pending
-
2006
- 2006-10-15 IL IL178561A patent/IL178561A0/en unknown
- 2006-11-16 NO NO20065270A patent/NO20065270L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20050265925A1 (en) | 2005-12-01 |
| KR20070010175A (ko) | 2007-01-22 |
| MXPA06012144A (es) | 2007-01-31 |
| CN1997399A (zh) | 2007-07-11 |
| AU2005238015A1 (en) | 2005-11-10 |
| CA2562527A1 (en) | 2005-11-10 |
| WO2005105154A8 (en) | 2007-02-15 |
| EP1748795A1 (en) | 2007-02-07 |
| WO2005105154A1 (en) | 2005-11-10 |
| ZA200609638B (en) | 2008-02-27 |
| IL178561A0 (en) | 2007-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20065270L (no) | Polymerkonjugat som kan frigjores ved milde tiolyttiske betingelser | |
| ECSP20027480A (es) | Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa | |
| MX2010003156A (es) | Derivados de aril amida substituida con tetrazol y usos de los mismos. | |
| CY1111489T1 (el) | Ενωσεις για την αναστολη του πρωτεασωματος | |
| WO2009010416A3 (en) | Inhibitors of 11b-hydroxysteroid dehydrogenase | |
| NO20044663L (no) | Chalicheamicinderivat-baererkonjugater | |
| WO2006122188A3 (en) | Tripeptides as hepatitis c virus inhibitors | |
| EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
| WO2007056205A3 (en) | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents | |
| EA200602196A1 (ru) | Производные пиразола, композиции, содержащие эти соединения, и способы применения | |
| BRPI0508824A (pt) | conjugados de caliqueamicina | |
| IL184898A0 (en) | Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same | |
| WO2008057802A3 (en) | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same | |
| EA200870545A1 (ru) | Новые гетероциклические соединения | |
| EP2676679A3 (en) | Formulations which stabilize and inhibit precipitation of immunogenic compositions | |
| EA200970273A1 (ru) | Применение 2-6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2н-пиримидин-1-илметил-4-фторбензонитрила | |
| WO2007021970A3 (en) | Stable pharmaceutical formulations and methods of use thereof | |
| NO20064327L (no) | Tetracycliske laktamderivater og anvedelse derav | |
| WO2007016674A3 (en) | 2-aminoaryl pyridines as protein kinases inhibitors | |
| WO2006050930A3 (en) | Conjugates with enhanced cell uptake activity | |
| WO2011018635A3 (en) | Photosensitizing compositions | |
| WO2008139206A3 (en) | Optical imaging agents | |
| NO20070502L (no) | Azaindoler nyttige som inhibitorer av proteinkinaser | |
| NO20076053L (no) | Pyrazolpyrimidinderivat for behandling og forebygging av leversykdom | |
| EA200870434A1 (ru) | Аминопроизводные андростанов и андростенов как лекарственные средства против сердечно-сосудистых нарушений |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |